These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33484937)

  • 21. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes in hippocampal volume in the Edinburgh High Risk Study of Schizophrenia.
    Bois C; Levita L; Ripp I; Owens DCG; Johnstone EC; Whalley HC; Lawrie SM
    Schizophr Res; 2016 Jun; 173(3):146-151. PubMed ID: 25534070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of gene dosage and development on subcortical nuclei volumes in individuals with 22q11.2 copy number variations.
    Schleifer CH; O'Hora KP; Fung H; Xu J; Robinson TA; Wu AS; Kushan-Wells L; Lin A; Ching CRK; Bearden CE
    Neuropsychopharmacology; 2024 May; 49(6):1024-1032. PubMed ID: 38431758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-reduction in hippocampal volume is associated with higher risk of psychosis.
    Phillips LJ; Velakoulis D; Pantelis C; Wood S; Yuen HP; Yung AR; Desmond P; Brewer W; McGorry PD
    Schizophr Res; 2002 Dec; 58(2-3):145-58. PubMed ID: 12409154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis.
    Borgan F; Laurikainen H; Veronese M; Marques TR; Haaparanta-Solin M; Solin O; Dahoun T; Rogdaki M; Salokangas RK; Karukivi M; Di Forti M; Turkheimer F; Hietala J; Howes O;
    JAMA Psychiatry; 2019 Oct; 76(10):1074-1084. PubMed ID: 31268519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term Medication Effects on Brain Functional Activity and Network Architecture in First-Episode psychosis: a longitudinal fMRI study.
    Zhang Y; Xiang Q; Huang CC; Zhao J; Liu Y; Lin CP; Liu D; Lo CZ
    Brain Imaging Behav; 2023 Apr; 17(2):137-148. PubMed ID: 36646973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between amygdala nuclei volumes, psychosis, psychopathy, and violent offending.
    Bell C; Tesli N; Gurholt TP; Rokicki J; Hjell G; Fischer-Vieler T; Melle I; Agartz I; Andreassen OA; Rasmussen K; Johansen R; Friestad C; Haukvik UK
    Psychiatry Res Neuroimaging; 2022 Jan; 319():111416. PubMed ID: 34847406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered hippocampal centrality and dynamic anatomical covariance of intracortical microstructure in first episode psychosis.
    Makowski C; Lewis JD; Khundrakpam B; Tardif CL; Palaniyappan L; Joober R; Malla A; Shah JL; Bodnar M; Chakravarty MM; Evans AC; Lepage M
    Hippocampus; 2020 Oct; 30(10):1058-1072. PubMed ID: 32485018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced anterior internal capsule and thalamic volumes in first-episode psychosis.
    Lang DJ; Khorram B; Goghari VM; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Honer WG
    Schizophr Res; 2006 Oct; 87(1-3):89-99. PubMed ID: 16793239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial.
    Chopra S; Francey SM; O'Donoghue B; Sabaroedin K; Arnatkeviciute A; Cropley V; Nelson B; Graham J; Baldwin L; Tahtalian S; Yuen HP; Allott K; Alvarez-Jimenez M; Harrigan S; Pantelis C; Wood SJ; McGorry P; Fornito A
    JAMA Psychiatry; 2021 Sep; 78(9):994-1004. PubMed ID: 34160595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thalamic dysconnectivity in the psychosis risk syndrome and early illness schizophrenia.
    Fryer SL; Ferri JM; Roach BJ; Loewy RL; Stuart BK; Anticevic A; Ford JM; Mathalon DH
    Psychol Med; 2022 Oct; 52(13):2767-2775. PubMed ID: 33719985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of initial antipsychotic treatment on hippocampal and amygdalar volume in first-episode schizophrenia is influenced by age.
    Xia M; Wang Y; Su W; Tang Y; Zhang T; Cui H; Wei Y; Tang X; Xu L; Hu H; Guo Q; Qian Z; Wu X; Li C; Wang J
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Aug; 126():110780. PubMed ID: 37141986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amygdala volume is reduced in early course schizophrenia.
    Rich AM; Cho YT; Tang Y; Savic A; Krystal JH; Wang F; Xu K; Anticevic A
    Psychiatry Res Neuroimaging; 2016 Apr; 250():50-60. PubMed ID: 27035063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Functional Coupling between VTA and Hippocampus during Rest in First-Episode Psychosis.
    Gregory DF; Rothrock JM; Jalbrzikowski M; Foran W; Montez DF; Luna B; Murty VP
    eNeuro; 2021; 8(2):. PubMed ID: 33658310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. History of suicide attempt associated with amygdala and hippocampus changes among individuals with schizophrenia.
    Yin Y; Tong J; Huang J; Wang L; Tian B; Chen S; Tan S; Wang Z; Yu T; Li Y; Tong Y; Fan F; Kochunov P; Hong LE; Tan Y
    Eur Arch Psychiatry Clin Neurosci; 2023 Jun; 273(4):921-930. PubMed ID: 36788147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State-dependent microstructural white matter changes in drug-naïve patients with first-episode psychosis.
    Serpa MH; Doshi J; Erus G; Chaim-Avancini TM; Cavallet M; van de Bilt MT; Sallet PC; Gattaz WF; Davatzikos C; Busatto GF; Zanetti MV
    Psychol Med; 2017 Nov; 47(15):2613-2627. PubMed ID: 28826419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gray matter differences between affective and non-affective first episode psychosis: A review of Magnetic Resonance Imaging studies: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    Calvo A; Delvecchio G; Altamura AC; Soares JC; Brambilla P
    J Affect Disord; 2019 Jan; 243():564-574. PubMed ID: 29625792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gray and white matter changes and their relation to illness trajectory in first episode psychosis.
    Keymer-Gausset A; Alonso-Solís A; Corripio I; Sauras-Quetcuti RB; Pomarol-Clotet E; Canales-Rodriguez EJ; Grasa-Bello E; Álvarez E; Portella MJ
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):392-400. PubMed ID: 29338891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volume deficits in hippocampal subfields in unaffected relatives of schizophrenia patients with high genetic loading but without any psychiatric symptoms.
    Choi S; Kim M; Park H; Kim T; Moon SY; Lho SK; Lee J; Kwon JS
    Schizophr Res; 2022 Feb; 240():125-131. PubMed ID: 34999371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor abnormalities and basal ganglia in first-episode psychosis (FEP).
    Cuesta MJ; Lecumberri P; Moreno-Izco L; López-Ilundain JM; Ribeiro M; Cabada T; Lorente-Omeñaca R; de Erausquin G; García-Martí G; Sanjuan J; Sánchez-Torres AM; Gómez M; Peralta V
    Psychol Med; 2021 Jul; 51(10):1625-1636. PubMed ID: 32114994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.